Published in Nat Methods on March 09, 2015
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science (2016) 2.21
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission. PLoS Pathog (2015) 1.71
A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet (2016) 1.43
International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med (2016) 1.29
ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc Natl Acad Sci U S A (2016) 0.85
Drug delivery strategies and systems for HIV/AIDS pre-exposure prophylaxis and treatment. J Control Release (2015) 0.83
TFH in HIV Latency and as Sources of Replication-Competent Virus. Trends Microbiol (2016) 0.82
Persistent HIV-1 replication during antiretroviral therapy. Curr Opin HIV AIDS (2016) 0.81
New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget (2016) 0.81
HIV-1 Latency and Eradication: Past, Present and Future. Curr HIV Res (2016) 0.80
Discordance in lymphoid tissue recovery following stem cell transplantation in rhesus macaques: an in vivo imaging study. Blood (2015) 0.79
Maintaining lung health with longstanding HIV. Curr Opin Infect Dis (2016) 0.79
Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs. Front Immunol (2015) 0.77
Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research. J Transl Med (2016) 0.76
Non-invasive nuclear imaging for localization of viral reservoirs. Nat Methods (2015) 0.76
APOBEC4 Enhances the Replication of HIV-1. PLoS One (2016) 0.76
Imaging lymphoid tissues in nonhuman primates to understand SIV pathogenesis and persistence. Curr Opin Virol (2016) 0.76
Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies. J Infect Dis (2017) 0.75
The Promise of Molecular Imaging in the Study and Treatment of Infectious Diseases. Mol Imaging Biol (2017) 0.75
Whole body MRI of the non-human primate using a clinical 3T scanner: initial experiences. Quant Imaging Med Surg (2017) 0.75
Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals. Front Med (Lausanne) (2016) 0.75
Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy? Curr Opin Virol (2016) 0.75
Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog (2016) 0.75
Has molecular imaging delivered to drug development? Philos Trans A Math Phys Eng Sci (2017) 0.75
Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science (1998) 12.81
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science (2010) 10.69
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog (2013) 6.14
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol (2006) 4.26
Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med (2011) 2.96
Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure. PLoS Pathog (2010) 2.55
Immunopathogenesis of acute AIDS virus infection. Curr Opin Immunol (2006) 2.11
Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog (2013) 2.02
Prospects for treatment of latent HIV. Clin Pharmacol Ther (2012) 1.91
Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med (2007) 1.76
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS (2012) 1.59
Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J Virol (2000) 1.48
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer. J Nucl Med (2013) 1.46
Localization of Simian immunodeficiency virus-infected cells in the genital tract of male and female Rhesus macaques. J Reprod Immunol (1998) 1.41
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med (2006) 1.38
Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. Am J Pathol (1993) 1.37
Optimizing HIV treatment. Curr Opin HIV AIDS (2013) 1.33
PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci (2008) 1.23
Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol (2011) 1.18
Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection. PLoS One (2013) 1.16
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. J Nucl Med (2013) 1.14
Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates. Blood (2009) 1.09
Immunodeficiency lentiviral infections in natural and non-natural hosts. Blood (2011) 1.09
Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: compartmentalized regulation of SIV. J Infect Dis (2006) 1.06
HIV infection of the male genital tract--consequences for sexual transmission and reproduction. Int J Androl (2009) 1.01
FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging (2008) 1.00
Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source. Virol J (2007) 0.95
Immuno-PET of cancer: a revival of antibody imaging. J Nucl Med (2011) 0.94
Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Front Immunol (2013) 0.91
Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology (2008) 0.91
The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the post-acute stage of infection. Retrovirology (2007) 0.90
Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide. Expert Opin Drug Deliv (2013) 0.85
Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies. Eur J Nucl Med Mol Imaging (2007) 0.82
Increased FDG uptake in association with reduced extremity fat in HIV patients. Antivir Ther (2012) 0.81
Human immunodeficiency virus type 1 variability and long-term non-progression. J Biol Regul Homeost Agents (2001) 0.81
Cytokine enhancement of simian immunodeficiency virus (SIV/mac) from a chronically infected cloned T-cell line (HuT-78). Arch Virol (1991) 0.81
Preferred antiretroviral drugs for the next decade of scale up. J Int AIDS Soc (2012) 0.80
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection. Nat Med (2014) 1.32
Probes for intracellular RNA imaging in live cells. Methods Enzymol (2012) 0.89
Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J Virol (2014) 0.89
Autoimmunity and HIV/simian immunodeficiency virus infection: A two edged sword. Hepatol Res (2007) 0.77
Correlated fluorescence microscopy and cryo-electron tomography of virus-infected or transfected mammalian cells. Nat Protoc (2016) 0.75